EAM
ANIP icon

Eagle Asset Management’s ANI Pharmaceuticals ANIP Stock Holding History

Eagle Asset Management’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$2.19M Buy
+35,630
New +$2.17M 0.01% 453
2020
Q3 		– Sell
-62,046
Closed -$1.94M – 571
2020
Q2 		$1.94M Sell
62,046
-63,632
-51% -$2.28M 0.01% 447
2020
Q1 		$5.12M Buy
+125,678
New +$6.68M 0.03% 358

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.58B AUM 51% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Eagle Asset Management's ANIP Position: Q3 2024 in Review

Eagle Asset Management opened a new position in ANI Pharmaceuticals (ANIP) in Q3 2024: 35,630 shares worth $2.19M. The stake represents 0.01% of the portfolio and ranks #453 among its holdings. This is a return to the name: Eagle Asset Management previously reported a position in ANIP as recently as Q2 2020.

Eagle Asset Management first reported a position in ANIP in Q1 2020 and has held it in 3 quarters since. The position peaked at $5.12M in Q1 2020. 208 funds tracked by Wall St. Rank hold ANIP as of Q3 2024.

  • Eagle Asset Management held 35,630 shares of ANI Pharmaceuticals worth $2.19M as of Q3 2024.
  • ANI Pharmaceuticals was a new Eagle Asset Management position in Q3 2024.
  • ANI Pharmaceuticals made up 0.01% of Eagle Asset Management's portfolio in Q3 2024, its #453 holding.
  • Eagle Asset Management first reported a position in ANI Pharmaceuticals in Q1 2020 and has held it in 3 quarters since.
  • Eagle Asset Management's ANI Pharmaceuticals position peaked at $5.12M in Q1 2020.
  • 208 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q3 2024.

Based on Eagle Asset Management's 13F filing for Q3 2024, filed 12 Nov 2024.